Research Projects & Grants

For Profit Organization

  • A phase 3b, open-label, randomized, parallel-group, multi-center study to evaluate the safety of Novartis MenACWY conjugate vaccine when administered with routine infant vaccinations to healthy infants, Role: Investigator, Novartis Vaccines and Diagnostics, Inc., (01/2011 - 01/2012) Status: Completed
  • A phase 3, open-label trial evaluating the safety, tolerability, and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy children, aged 15 months to 17 years in the United States, Role: Investigator, Wyeth Pharmaceuticals, Inc., (09/2010 - 09/2011) Status: Completed
  • A phase 2, randomized, active-controlled, observer-blinded trial, to assess the safety, tolerability, and immunogenicity of MCV4, Tdap vaccine and rLP2086 vaccine when administered concomitantly in healthy aged = 10 to < 13 years, Role: PI, Pfizer Pharmaceuticals, Status: Completed

Internal

  • Giving feedback-learned?, Role: PI, LLU Dept. of Pediatrics, (06/2012) Status: Completed

State

  • Song-Brown Healthcare Workforce Training Program Grant-THC SACHS, Role: Faculty, Office of Statewide Health Planning and Development, (01/2020 - 09/2021) Status: Closed